Equity | NOTE 6 – Equity Preferred shares We are authorized to issue 4,999,000 Series B On July 19, 2022, the Company designated 1,000,000 5,000,000 0.001 8 65 25 During the year ended December 31, 2022, the Company entered into purchase agreements for the sale of 212,500 11,250 201,250 On January 25, 2023, the Company redeemed the Preferred B shares and paid to the holder a total of $ 270,549 212,500 6,190 51,859 Common shares The Company has authorized 950,000,000 0.001 390,687,459 On March 30, 2023, the Company entered into a settlement agreement with a previous note holder for settlement of outstanding claims of a note payable that had been paid in full previously. Per the terms of the settlement agreement, the Company issued 250,000 9,975 Stock Options During the three months ended March 31, 2023, the Company granted to each of Charlie Faulkner and Simon Wajcenberg, the Chief Executive Officer and Chief Financial Officer of the Company, respectively, options to purchase up to 77,000,000 0.04 5 15 4,814,035 On January 25, 2023, the Company amended stock option grants dated January 31, 2022 to each of Charlie Faulkner and Simon Wajcenberg, the Chief Executive Officer and Chief Financial Officer of the Company, respectively. The amendment reduces the exercise price of the options from $0.40 per share to $0.06 per share. As a result of the amendment, the Company recorded an additional $ 1,236,487 On March 3, 2023, the Company amended stock option grants dated September 12, 2022 to each of Charlie Faulkner and Simon Wajcenberg, the Chief Executive Officer and Chief Financial Officer of the Company, respectively. The amendment provides for the vesting to be only upon the closing of the purchase of at least $ 15 As of March 31, 2023, the Company has $ 22,529,707 21,679,711 15 0 The following table summarizes the stock option activity for the three months ended March 31, 2023: Schedule of option activity Options Weighted-Average Exercise Price Per Share Outstanding, December 31, 2022 239,284,669 $ 0.12 Granted 154,000,000 0.04 Exercised – – Forfeited – – Expired – – Outstanding, March 31, 2023 393,284,669 $ 0.09 As of March 31, 2023, the Company had 85,907,990 4.75 0 4,385 Stock Warrants The following table summarizes the stock warrant activity for the three months ended March 31, 2022: Schedule of warrant activity Warrants Weighted-Average Exercise Price Per Share Outstanding, December 31, 2022 9,530,000 $ 0.50 Granted – – Exercised – – Forfeited – – Expired – – Outstanding, March 31, 2023 9,530,000 $ 0.50 |